<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33782171</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1488-2329</ISSN><JournalIssue CitedMedium="Internet"><Volume>193</Volume><Issue>13</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title><ISOAbbreviation>CMAJ</ISOAbbreviation></Journal><ArticleTitle>Burden of noninfluenza respiratory viral infections in adults admitted to hospital: analysis of a multiyear Canadian surveillance cohort from 2 centres.</ArticleTitle><Pagination><StartPage>E439</StartPage><EndPage>E446</EndPage><MedlinePgn>E439-E446</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.201748</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Data on the outcomes of noninfluenza respiratory virus (NIRV) infections among hospitalized adults are lacking. We aimed to study the burden, severity and outcomes of NIRV infections in this population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed pooled patient data from 2 hospital-based respiratory virus surveillance cohorts in 2 regions of Canada during 3 consecutive seasons (2015/16, 2016/17, 2017/18; <i>n</i> = 2119). We included patients aged &#x2265; 18 years who developed influenza-like illness or pneumonia and were hospitalized for management. We included patients confirmed positive for &#x2265; 1 virus by multiplex polymerase chain reaction assays (respiratory syncytial virus [RSV], human rhinovirus/enterovirus (hRV), human coronavirus (hCoV), metapneumovirus, parainfluenza virus, adenovirus, influenza viruses). We compared patient characteristics, clinical severity conventional outcomes (e.g., hospital length-of stay, 30-day mortality) and ordinal outcomes (5 levels: discharged, receiving convalescent care, acute ward or intensive care unit [ICU] care and death) for patients with NIRV infections and those with influenza.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 2119 adults who were admitted to hospital, 1156 patients (54.6%) had NIRV infections (hRV 14.9%, RSV 12.9%, hCoV 8.2%) and 963 patients (45.4%) had influenza (<i>n</i> = 963). Patients with NIRVs were younger (mean 66.4 [standard deviation 20.4] yr), and more commonly had immunocompromising conditions (30.3%) and delay in diagnosis (median 4.0 [interquartile range (IQR) 2.0-7.0] days). Overall, 14.6% (12.4%-19.5%) of NIRV infections were acquired in hospital. Admission to ICU (18.2%, median 6.0 [IQR 3.0-13.0] d), hospital length-of-stay (median 5.0 [IQR 2.0-10.0] d) and 30-day mortality (8.4%; RSV 9.5%, hRV 6.6%, hCoV 9.2%) and the ordinal outcomes were similar for patients with NIRV infection and those with influenza. Age &gt; 60 years, immunocompromised state and hospital-acquired viral infection were associated with worse outcomes. The estimated median cost per acute care admission was $6000 (IQR $2000-$16 000).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">The burden of NIRV infection is substantial in adults admitted to hospital and associated outcomes may be as severe as for influenza, suggesting a need to prioritize therapeutics and vaccines for at-risk people.</AbstractText><CopyrightInformation>&#xa9; 2021 Joule Inc. or its licensors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont. samira.mubareka@sunnybrook.ca laishunn@ualberta.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelyas</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klarenbach</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zapernick</LastName><ForeName>Lori</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekking</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>So</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Lily</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tipples</LastName><ForeName>Graham</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Geoff</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mubareka</LastName><ForeName>Samira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease (Lee, Smith, Zapernick, Taylor), Department of Medicine, and Department of Laboratory Medicine and Pathology (Zelyas, Tipples), and Division of Nephrology (Klarenbach, So), Department of Medicine, University of Alberta, Edmonton, Alta.; Sunnybrook Research Institute (Bekking, Yip, Mubareka); Department of Laboratory Medicine and Pathobiology (Mubareka), University of Toronto, Toronto, Ont. samira.mubareka@sunnybrook.ca laishunn@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>CMAJ</MedlineTA><NlmUniqueID>9711805</NlmUniqueID><ISSNLinking>0820-3946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: Nelson Lee declares honoraria for consultancy work, speaking in educational programs or travel support from Shionogi, Gilead Sciences Canada, Janssen Pharmaceuticals, Sanofi-Pasteur, F. Hoffmann-La Roche, Genentech, CIDARA Therapeutics, outside the submitted work. Scott Klarenbach is supported by the Kidney Health Research Chair, and the Division of Nephrology at the University of Alberta, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33782171</ArticleId><ArticleId IdType="pmc">PMC8099164</ArticleId><ArticleId IdType="doi">10.1503/cmaj.201748</ArticleId><ArticleId IdType="pii">193/13/E439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2016 Lower Respiratory Infections Collaborators; Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 2018;18:1191&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202443</ArticleId><ArticleId IdType="pubmed">30243584</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Self WH, Wunderink RG, et al. .; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015;373:415&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728150</ArticleId><ArticleId IdType="pubmed">26172429</ArticleId></ArticleIdList></Reference><Reference><Citation>Brendish NJ, Malachira AK, Armstrong L, et al. . Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 2017;5:401&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164815</ArticleId><ArticleId IdType="pubmed">28392237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Wang Y, Liu Y, et al. .; CAP-China Network. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network. Eur Respir J 2019;54:1802406.</Citation><ArticleIdList><ArticleId IdType="pubmed">31164430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ieven M, Coenen S, Loens K, et al. .; GRACE consortium. Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries. Clin Microbiol Infect 2018;24:1158&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129248</ArticleId><ArticleId IdType="pubmed">29447989</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi T, Arnott A, Semogas I, et al. .; RESCEU Investigators. The etiological role of common respiratory viruses in acute respiratory infections in older adults: a systematic review and meta-analysis. J Infect Dis 2020;222(Suppl 7):S563&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107439</ArticleId><ArticleId IdType="pubmed">30849176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JW, Lam TT, Zaraket H, et al. .; INSPIRE investigators. Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance. Lancet Infect Dis 2017;17:e320&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164797</ArticleId><ArticleId IdType="pubmed">28457597</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter JM, Wunderink RG. Severe respiratory viral infections: new evidence and changing paradigms. Infect Dis Clin North Am 2017;31:455&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347414</ArticleId><ArticleId IdType="pubmed">28687214</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama F, Nace DA, Jump RLP. Respiratory syncytial virus and other noninfluenza respiratory viruses in older adults. Infect Dis Clin North Am 2017;31:767&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846091</ArticleId><ArticleId IdType="pubmed">29079159</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin Microbiol Rev 2017;30:277&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5217795</ArticleId><ArticleId IdType="pubmed">27903593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Lui GCY, Wong KT, et al. . High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 2013;57:1069&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">23876395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerson B, Tseng HF, Sy LS, et al. . Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis 2019;69:197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6603263</ArticleId><ArticleId IdType="pubmed">30452608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Walsh EE, Sander I, et al. . Delayed diagnosis of respiratory syncytial virus infections in hospitalized adults: individual patient data, record review analysis and physician survey in the United States. J Infect Dis 2019;220:969&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6688061</ArticleId><ArticleId IdType="pubmed">31070757</ArticleId></ArticleIdList></Reference><Reference><Citation>Drews SJ, Branche AR, Falsey AR, et al. . What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections? J Clin Virol 2019;117:27&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">31158780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Smith SW, Hui DSC, et al. . Development of an ordinal scale treatment endpoint in adults hospitalized with influenza. Clin Infect Dis 2020. June 17 [Epub ahead of print]. 10.1093/cid/ciaa777</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa777</ArticleId><ArticleId IdType="pubmed">32827251</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozak R, Prost K, Yip L, et al. . Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario. J Clin Virol 2020;126:104338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7142695</ArticleId><ArticleId IdType="pubmed">32278299</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathima S, Lee BE, May-Hadford J, et al. . Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human meta-pneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009&#x2013;2012). Viruses 2012;4:2754&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3509671</ArticleId><ArticleId IdType="pubmed">23202503</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonsalves S, Mahony J, Rao A, et al. . Multiplexed detection and identification of respiratory pathogens using the NxTAG&#xae; respiratory pathogen panel. Methods 2019;158:61&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128802</ArticleId><ArticleId IdType="pubmed">30660863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko FW-S, Chan PK-S, Chan RWY, et al. . Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease. Respir Res 2019;20:210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6743175</ArticleId><ArticleId IdType="pubmed">31519188</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundell N, Andersson L-M, Brittain-Long R, et al. . PCR detection of respiratory pathogens in asymptomatic and symptomatic adults. J Clin Microbiol 2019;57: e00716&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322459</ArticleId><ArticleId IdType="pubmed">30355759</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus disease (COVID-19) pandemic. Geneva: World Health Organization. Available: www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed 2021 Jan. 15).</Citation></Reference><Reference><Citation>Monto AS, DeJonge PM, Callear AP, et al. . Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan. J Infect Dis 2020;222:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184402</ArticleId><ArticleId IdType="pubmed">32246136</ArticleId></ArticleIdList></Reference><Reference><Citation>King JC, Beigel JH, Ison MG, et al. . Clinical development of therapeutic agents for hospitalized patients with influenza: challenges and innovations. Open Forum Infect Dis 2019;6:ofz137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6479095</ArticleId><ArticleId IdType="pubmed">31037242</ArticleId></ArticleIdList></Reference><Reference><Citation>Care in Canadian ICUs. Ottawa: Canadian Institute for Health Information; 2016.</Citation></Reference><Reference><Citation>Table 18-10-0005-01: Consumer Price Index, annual average, not seasonally adjusted. Ottawa: Statistics Canada. Available: www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1810000501 (accessed 2020 Sept. 15).</Citation></Reference><Reference><Citation>Corman VM, Muth D, Niemeyer D, et al. . Hosts and sources of endemic human coronaviruses. Adv Virus Res 2018;100:163&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112090</ArticleId><ArticleId IdType="pubmed">29551135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogimi C, Waghmare AA, Kuypers JM, et al. . Clinical significance of human coronavirus in bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2017;64:1532&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5434339</ArticleId><ArticleId IdType="pubmed">28329354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand J, Rose EB, Salinas A, et al. . Severe respiratory illness outbreak associated with human coronavirus NL63 in a long-term care facility. Emerg Infect Dis 2018;24:1964&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6154147</ArticleId><ArticleId IdType="pubmed">30226169</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Lamson DM, St George K, et al. . Human rhinoviruses. Clin Microbiol Rev 2013;26:135&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller EK, Linder J, Kraft D, et al. . Hospitalizations and outpatient visits for rhinovirus-associated acute respiratory illness in adults. J Allergy Clin Immunol 2016;137:734&#x2013;43.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744574</ArticleId><ArticleId IdType="pubmed">26255695</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmer K, Griffin MR, Zhu Y, et al. . Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults. Influenza Other Respir Viruses 2014;8:347&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984605</ArticleId><ArticleId IdType="pubmed">24512531</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell E, Yang A, Tardrew S, et al. . Parainfluenza virus in hospitalized adults: a 7-year retrospective study. Clin Infect Dis 2019;68:298&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">29961826</ArticleId></ArticleIdList></Reference><Reference><Citation>Brendish NJ, Clark TW. Antiviral treatment of severe non-influenza respiratory virus infection. Curr Opin Infect Dis 2017;30:573&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29095723</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor G, Mitchell R, McGeer A, et al. .; Canadian Nosocomial Infection Surveillance Program. Healthcare-associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol 2014;35:169&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">24442080</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco N, Eisenberg MC, Stillwell T, et al. . What transmission precautions best control influenza spread in a hospital? Am J Epidemiol 2016;183:1045&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">27188950</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbino J, Crespo S, Aubert J-D, et al. . A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin Infect Dis 2006;43:1009&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107919</ArticleId><ArticleId IdType="pubmed">16983613</ArticleId></ArticleIdList></Reference><Reference><Citation>Putri WCWS, Muscatello DJ, Stockwell MS, et al. . Economic burden of seasonal influenza in the United States. Vaccine 2018;36:3960&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29801998</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick AM, Monto AS, Nightengale B, et al. . The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003;163:487&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">12588210</ArticleId></ArticleIdList></Reference><Reference><Citation>Amand C, Tong S, Kieffer A, et al. . Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis. BMC Health Serv Res 2018;18:294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910575</ArticleId><ArticleId IdType="pubmed">29678177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerson B, An J, Sy LS, et al. . Cost of hospitalization associated with respiratory syncytial virus infection versus influenza infection in hospitalized older adults. J Infect Dis 2020;222:962&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32300806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>